Teriflunomide reduces relapse-related sequelae, hospitalizations and corticosteroid use: A post-HOC analysis of the phase 3 tower study

Authors
Category Primary study
JournalNeurology
Year 2013
This article has no abstract
Epistemonikos ID: 722a23477b845f66394545e3fa7687fcc047db80
First added on: Feb 05, 2025